{
    "Case ID": "020093",
    "Crime_Name": [
        "Patent Invalidity Dispute"
    ],
    "Crime_Type": [
        "Property Crimes"
    ],
    "Dispute_Type": [
        "Patent Invalidity"
    ],
    "Legal_Issue": [
        "Whether wilfulness is an essential element under subsection 53(1) of the Patent Act for a patent to be invalidated due to untrue material allegations"
    ],
    "Governing_Law": [
        "Patent Act, subsection 53(1)"
    ],
    "Procedural_Stage": [
        "Appeal from Prothonotary's decision"
    ],
    "Evidence_Assessment": [
        "Assessment of whether material allegations in the patent petition were untrue"
    ],
    "Decision_Outcome": [
        "Appeal dismissed"
    ],
    "Burden_of_Proof": [
        "On the party alleging invalidity to demonstrate untrue material allegations"
    ],
    "Credibility_Factor": [
        "Not explicitly addressed, but relevance of past cases cited by Teva considered"
    ],
    "Legal_Rule": [
        "A patent is void under subsection 53(1) if any material allegation in the petition is untrue"
    ],
    "Standard_of_Review": [
        "Plenary standard – whether the requirement of wilfulness is plainly and obviously required"
    ],
    "Procedural_Issue": [
        "Teva's motion to strike Apotex's defense"
    ],
    "Grounds_for_Claim": [
        "Untrue material allegations in the patent application"
    ],
    "Outcome_on_Merits": [
        "Wilfulness not required; Apotex's defense allowed to proceed"
    ],
    "Decision_Maker": [
        "Appeal judge"
    ],
    "Judicial_Review_Outcome": [
        "Appeal dismissed"
    ],
    "Review_Standard": [
        "Plainly and obviously interpretation of statutory provision"
    ],
    "Procedural_Fairness_Assessment": [
        "Prothonotary did not err in allowing Apotex's defense"
    ],
    "Key_Evidence_Considered": [
        "Material allegations in the patent petition, case law cited by Teva"
    ],
    "Legal_Framework": [
        "Canadian Patent Law"
    ],
    "Applicant_Challenge": [
        "Apotex challenged validity of Teva's patent"
    ],
    "Court_Result": [
        "Teva's appeal dismissed; costs awarded to Apotex"
    ],
    "Legal_Rule_Source": [
        "Statutory: Patent Act, s. 53(1); Case law references"
    ],
    "Standard_of_Proof": [
        "Balance of probabilities (implied in civil patent dispute)"
    ],
    "Defendant_Response": [
        "Apotex asserted patent invalidity as defense to infringement claim"
    ],
    "Evidence_Type": [
        "Documentary evidence (patent petition), legal precedents"
    ],
    "Remedy_Requested": [
        "Teva requested striking of Apotex's defense"
    ],
    "Outcome": [
        "Defense not struck; case allowed to continue"
    ],
    "Decision_Authority": [
        "Federal Court (appellate level)"
    ],
    "Remedy_Sought": [
        "Invalidation of patent based on untrue allegations"
    ],
    "Resolution_Mechanism": [
        "Judicial determination on motion to strike"
    ],
    "Legal_Provision": [
        "Patent Act, s. 53(1)"
    ],
    "Authority": [
        "Canadian Federal Court"
    ],
    "Claimant_Status": [
        "Teva as plaintiff in infringement action"
    ],
    "Legal_Provision_Cited": [
        "Patent Act, subsection 53(1)"
    ],
    "Grounds_for_Inadmissibility_or_Allegation": [
        "Allegation of untrue material statements in patent petition"
    ],
    "Applicable_Process": [
        "Motion to strike, followed by appeal"
    ],
    "Outcome_of_Review": [
        "Appeal dismissed"
    ],
    "Pending_Relief_or_Application": [
        "Apotex's defense of patent invalidity remains in play"
    ],
    "Jurisdiction": [
        "Federal jurisdiction – intellectual property"
    ],
    "Governing_Rule": [
        "Subsection 53(1) of the Patent Act"
    ]
}